Richard Steinhart
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard Steinhart
Richard Steinhart is recorded as CFO at BioXcel Therapeutics, Inc. (BTAIQ). The proxy statement of BioXcel Therapeutics, Inc. reports total compensation of $998,216 for Richard Steinhart in fiscal 2024, including a base salary of $409,872. Disclosed compensation is on record for 2 fiscal years. Richard Steinhart has spoken on 9 earnings calls across 1 company, most recently for BioXcel Therapeutics, Inc. on November 14, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at BioXcel Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David Mack Board Member
- Dr. Rajiv Patni Board Member
- June Bray Board Member
- Michael Miller Board Member
- Sandeep Laumas, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | BioXcel Therapeutics, Inc. (BTAIQ) | SVP and Chief Financial Officer | $409,872 | $998,216 |
| 2019 | BioXcel Therapeutics, Inc. (BTAIQ) | Chief Financial Officer | $285,600 | $403,997 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.